High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis. [PDF]
Blood, 2017 Key Points Some 10.1% of adults with non–Langerhans cell histiocytosis have a concomitant myeloid neoplasm with each often harboring distinct mutations. The presence of distinct kinase mutations in histiocytosis and myeloid neoplasms resulted in discordant responses to targeted therapy.
Papo M +22 more
europepmc +6 more sources
An unusual case of intracerebral Non-Langerhans cell histiocytosis with review of the literature [PDF]
Diagnostic Pathology, 2007 Conclusion This case shows the unusual manifestation of a primary intracerebral Non-Langerhans cell histiocytosis, which begins as a solid mass around the sellar region and shows a remarkable extension as a flat lining of inner and outer liquor spaces.
Klaus Mueller +4 more
openalex +5 more sources
A RARE CASE OF PULMONARY NON-LANGERHANS CELL HISTIOCYTOSIS [PDF]
Chest, 2020 Victoria González +3 more
openalex +3 more sources
Non-Langerhans cell histiocytosis in a child with Kawasaki disease
BMJ Case Reports, 2009 Polymorphous skin rashes are one of the major presentations in children with Kawasaki disease. This report describes an unusual presentation of a skin rash (non-Langerhans cell histiocytosis) in a 4-month-old baby with resistance to intravenous immunoglobulin (IVIG) treatment and coronary artery dilatation.
Ho‐Chang Kuo +6 more
openalex +6 more sources
A rare cutaneous lesion in the neonatal period: The non-Langerhans cell histiocytosis
Marmara Medical Journal, 2020 The non-Langerhans cell histiocytosis (non-LCH) is a group of diseases characterized by cutaneous involvement in the neonatal period. The non-LCH affects less than 1 in 200,000 children born each year. A definitive diagnosis is important for the treatment of the disease.
Adnan Barutçu +3 more
openalex +5 more sources
Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis [PDF]
Orphanet Journal of Rare Diseases, 2021 Abstract Background Non-Langerhans cell histiocytosis, including Erdheim–Chester disease (ECD), Rosai–Dorfman disease (RDD), indeterminate cell histiocytosis (ICH), and unclassified histiocytosis, is a rare disorder lacking a standard treatment strategy.
Ting Liu +7 more
openalex +6 more sources
Synovial Non-langerhans Cell Histiocytosis of the Shoulder: A Case Report and Review of the Literature. [PDF]
J Orthop Case Rep, 2020 Histiocytoses are rare disorders and most orthopedic surgeons are unfamiliar with this diagnosis. We report a case of synovial non-Langerhans cell histiocytosis (LCH) located in the shoulder, which has not been reported in the literature previously.A 24-year-old female patient presented to our clinic with shoulder pain and decreased range of motion ...
Huri G +3 more
europepmc +4 more sources
Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis. [PDF]
Mol Cancer Ther, 2019 Janku F +9 more
europepmc +3 more sources
MEK Inhibition with Trametinib in Patients with Non-Langerhans Cell Histiocytosis
Blood, 2019 Background: Activation of the MAPK pathway through BRAF mutations or other molecular alterations is a hallmark of the non-Lagerhans cell histiocytosis (non-LCH) such Erdheim-Chester disease (ECD) or Rosai-Dorfman disease (RDD). Conventional clinical molecular testing of tumor tissue fails to identify targetable molecular alteration in about one third ...
Filip Janků +5 more
openalex +3 more sources
NON-LANGERHANS CELLS HISTIOCYTOSIS ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS - CASE REPORT
SBR 2021 Congresso Brasileiro de Reumatologia, 2021 Izaura Tereza Silva Guedes +10 more
openalex +2 more sources